Next Milestone Ventures
![Screen Shot 2019-07-18 at 1.21.05 PM Screen Shot 2019-07-18 at 1.21.05 PM](https://www.nextmilestone.nyc/wp-content/uploads/2019/07/Screen-Shot-2019-07-18-at-1.21.05-PM-300x300.png)
Calder Biosciences
Calder Biosciences is a vaccine immunogen design company that is developing novel RSV and universal Influenza subunit vaccines, both representing $ multi-billion market opportunities with mitigated clinical risk.
Team:
Christopher Marshall, Ph.D., Chief Executive Officer
Mark Yonda, Ph. D., Director of Research
Next Milestone is a Program of